🔎 Trials Near Me

Akèy › Demans › Kalifòni

Etid klinik pou Demans nan Kalifòni

29 etid pou Demans ap chèche patisipan nan sit nan Kalifòni.

Vil nan Kalifòni

Tèks ofisyèl etid la (Anglè)

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

  • Clinical Site, Anaheim
  • Clinical Site, Long Beach
  • Clinical Site, Murrieta
  • ak 2 plis
Ap rekriteFaz 2
Laj 55 a 90 · Tout sèks · Mizajou Sep 30, 2026 · NCT06887192

A Study of LY3439539 in Participants With Alzheimer's Disease

  • Irvine Clinical Research, Irvine
  • Healthy Brain Clinic, Long Beach
  • Inglewood Clinical, Los Angeles
  • ak 1 plis
Ap rekriteFaz 1
Laj 50 a 85 · Tout sèks · Mizajou Sep 24, 2026 · NCT07598370

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

  • Fullerton Neurology and Headache Center, Fullerton
  • Irvine Clinical Research, Irvine
  • Inglewood Clinical, Los Angeles
  • ak 1 plis
Ap rekriteFaz 3
Laj 60 a 85 · Tout sèks · Mizajou Sep 17, 2026 · NCT06976203

Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type

  • Inland Psychiatric Medical Group, Chino
Ap rekriteFaz 2
Tout laj · Tout sèks · Mizajou Sep 16, 2026 · NCT06052254

Alzheimer's Tau Platform: Master Protocol

  • University of California, San Francisco, San Francisco
Ap rekriteFaz 2
Laj 50 a 80 · Tout sèks · Mizajou Sep 8, 2026 · NCT06957418

Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

  • Fresno VA Medical Center, Fresno
  • Long Beach VA Medical Center, Long Beach
  • Cedars-Sinai Medical Center, Los Angeles
  • ak 3 plis
Ap rekriteFaz 4Volontè an sante akeyi
Laj 75 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT04262206

Enhancing Attention and Wellbeing Using Digital Therapeutics

  • University of California San Francisco, San Francisco
Ap rekriteVolontè an sante akeyi
Laj 60 a 99 · Tout sèks · Mizajou Aug 24, 2026 · NCT06397469

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

  • Healthy Brain Clinic, Long Beach
  • Anderson Clinical Research, Redlands
Ap rekriteFaz 3
Laj 60 a 85 · Tout sèks · Mizajou Aug 20, 2026 · NCT06976216

Establishing Normal Cognitive Test Scores for Adults Using a Voice-Enabled Digital Testing Platform Across the Lifespan

  • The Neurology Center of Southern California, Carlsbad
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 100 · Tout sèks · Mizajou Aug 17, 2026 · NCT07763392

A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

  • University of California San Diego Medical Center, La Jolla
  • University of Southern Califonria, Los Angeles
Ap rekriteFaz 2/3Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT06647498

A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

  • University of California San Diego Medical Center, La Jolla
  • University of Southern Califonria, Los Angeles
Ap rekriteFaz 2/3Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT05552157

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

  • Care Access - Huntington Beach, Huntington Beach
  • Irvine Clinical Research, Irvine
  • Healthy Brain Clinic, Long Beach
  • ak 6 plis
Ap rekriteFaz 3
Laj 55 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT07602582

A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)

  • Inland Psychiatric Medical Group., Chino
Ap rekriteFaz 3
Laj 55 a 90 · Tout sèks · Mizajou Jun 30, 2026 · NCT06947941

A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

  • Irvine Center for Clinical Research, Irvine
  • University of California San Diego, La Jolla
  • University of California at Los Angeles, Los Angeles
Ap rekriteFaz 2
Laj 50 a 85 · Tout sèks · Mizajou Jun 26, 2026 · NCT07094516

A Dyadic Sleep Health Approach for Persons With Alzheimer's Disease and Caregivers

  • University of California San Diego, La Jolla
  • University of California Los Angeles, Los Angeles
  • Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jun 18, 2026 · NCT05452031

The INSPIRE -Faith Study: Intervention Strategies for Preserving Intellectual Resilience and Engagement

  • Crenshaw Christian Center, Los Angeles
Ap rekriteVolontè an sante akeyi
Laj 55 a 85 · Tout sèks · Mizajou May 28, 2026 · NCT06741865

Preventing Medication Mismanagement in People Living With Dementia

  • HiDO Technologies, Folsom
Ap rekrite
Laj 65 ak plis · Tout sèks · Mizajou May 22, 2026 · NCT07600684

Trial-Ready Cohort-Down Syndrome (TRC-DS)

  • University of California, Irvine School of Medicine, Co-Enrolling through ABC-DS Only, Orange
Ap rekriteEtid obsèvasyon
Laj 25 a 55 · Tout sèks · Mizajou May 18, 2026 · NCT04165109

New Approach to Objectively Measure Social Engagement in Older Adults With Hearing Loss

  • Los Angeles General Medical Center, Los Angeles
  • University of Southern California, Los Angeles
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 60 ak plis · Tout sèks · Mizajou May 11, 2026 · NCT06781749

Testing & Refinement of CarePair: An Assessment and Referral Platform to Support Family Caregivers of Alzheimer's Disease and Related Dementias.

  • University of Southern California, Los Angeles
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Mar 5, 2026 · NCT06418971

Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Study

  • University of California, Los Angeles
  • University of California, San Francisco
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jan 15, 2026 · NCT05677880

The Active Mind Trial: An Adaptive Randomized Trial to Improve Function and Delay Dementia

  • University of California San Francisco, San Francisco
Ap rekrite
Laj 55 a 89 · Tout sèks · Mizajou Dec 11, 2025 · NCT04171323

Dementia and Diabetes Prevention Program

  • University of California, Davis Alzheimer's Disease Center, Walnut Creek
Ap rekrite
Laj 60 ak plis · Tout sèks · Mizajou Dec 5, 2025 · NCT04141878

Transcranial Photobiomodulation (tPBM) in Alzheimer's Disease Study

  • CSMC, Los Angeles
Ap rekrite
Laj 55 a 89 · Tout sèks · Mizajou Nov 19, 2025 · NCT07224607

TabCAT Brain Health Assessment in Primary Care

  • Kaiser Permanente Southern California Department of Research & Evaluation, Pasadena
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Oct 31, 2025 · NCT06090578

Alzheimer Prevention Trials (APT) Webstudy

  • Https://Www.Aptwebstudy.Org, San Diego
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 50 a 85 · Tout sèks · Mizajou Jul 16, 2025 · NCT03638583

First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in Dementia

  • China Basin, UCSF, San Francisco
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 40 a 75 · Tout sèks · Mizajou Apr 17, 2025 · NCT05374278

Phase I Human Analytics (HALO) Study

  • Desert Medical Imaging, Indian Wells
Ap rekriteEtid obsèvasyon
Laj 45 a 90 · Gason · Mizajou Oct 14, 2022 · NCT05423860

Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions

  • Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites, Culver City
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Apr 29, 2022 · NCT04684602

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.